Development and Validation of Models to Predict Lymph Node Metastasis in Early Gastric Cancer Using Logistic Regression and Gradient Boosting Machine Methods
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose This study aimed to identify important features of lymph node metastasis (LNM) and develop a prediction model for early gastric cancer (EGC) using a gradient boosting machine (GBM) method. Materials and Methods The clinicopathologic data of 2,556 patients with EGC who underwent gastrectomy were used as training set and the internal validation set (set 1) at a ratio of 8:2. Additionally, 548 patients with EGC who underwent endoscopic submucosal dissection (ESD) as the initial treatment were included in the external validation set (set 2). The GBM model was constructed, and its performance was compared with that of the Japanese guidelines. Results LNM was identified in 12.6% (321/2,556) of the gastrectomy group (training set & set 1) and 4.3% (24/548) of the ESD group (set 2). In the GBM analysis, the top five features that most affected LNM were lymphovascular invasion, depth, differentiation, size, and location. The accuracy, sensitivity, specificity, and the area under the receiver operating characteristics of set 1 were 0.566, 0.922, 0.516, and 0.867, while those of set 2 were 0.810, 0.958, 0.803, and 0.944, respectively. When the sensitivity of GBM was adjusted to that of Japanese guidelines (beyond the expanded criteria in set 1 [0.922] and eCuraC-2 in set 2 [0.958]), the specificities of GBM in sets 1 and 2 were 0.516 (95% confidence interval, 0.502-0.523) and 0.803 (0.795-0.805), while those of the Japanese guidelines were 0.502 (0.488-0.509) and 0.788 (0.780-0.790), respectively. Conclusion The GBM model showed good performance comparable with the eCura system in predicting LNM risk in EGCs.
Abstract
Purpose This study aimed to identify important features of lymph node metastasis (LNM) and develop a prediction model for early gastric cancer (EGC) using a gradient boosting machine (GBM) method. Materials and Methods The clinicopathologic data of 2,556 patients with EGC who underwent gastrectomy were used as training set and the internal validation set (set 1) at a ratio of 8:2. Additionally, 548 patients with EGC who underwent endoscopic submucosal dissection (ESD) as the initial treatment were included in the external validation set (set 2). The GBM model was constructed, and its performance was compared with that of the Japanese guidelines. Results LNM was identified in 12.6% (321/2,556) of the gastrectomy group (training set & set 1) and 4.3% (24/548) of the ESD group (set 2). In the GBM analysis, the top five features that most affected LNM were lymphovascular invasion, depth, differentiation, size, and location. The accuracy, sensitivity, specificity, and the area under the receiver operating characteristics of set 1 were 0.566, 0.922, 0.516, and 0.867, while those of set 2 were 0.810, 0.958, 0.803, and 0.944, respectively. When the sensitivity of GBM was adjusted to that of Japanese guidelines (beyond the expanded criteria in set 1 [0.922] and eCuraC-2 in set 2 [0.958]), the specificities of GBM in sets 1 and 2 were 0.516 (95% confidence interval, 0.502-0.523) and 0.803 (0.795-0.805), while those of the Japanese guidelines were 0.502 (0.488-0.509) and 0.788 (0.780-0.790), respectively. Conclusion The GBM model showed good performance comparable with the eCura system in predicting LNM risk in EGCs.
참고문헌 (30)
- Sung H, "Global cancer statistics 2020 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 71, pp.209~249 (2021)
- 이준행, "Clinical Practice Guidelines for Gastric Cancer in Korea: An Evidence-Based Approach", Journal of Gastric Cancer, 14(2), pp.87~104 (2014), 대한위암학회[DOI]
- Ono H, "Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer", Dig Endosc, 28, pp.3~15 (2016)
- Ono H, "Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer(second edition)", Dig Endosc, 33, pp.4~20 (2021)
- Yamao T, "Risk factors for lymph node metastasis from intramucosal gastric carcinoma", Cancer, 77, pp.602~606 (1996)
- Yasuda K, "Rate of detection of lymph node metastasis is correlated with the depth of submucosal invasion in early stage gastric carcinoma", Cancer, 85, pp.2119~2123 (1999)
- Ren G, "Prediction of risk factors for lymph node metastasis in early gastric cancer", World J Gastroenterol, 19, pp.3096~3107 (2013)
- Kim SM, "A prediction model for lymph node metastasis in early-stage gastric cancer : toward tailored lymphadenectomy", J Surg Oncol, 120, pp.670~675 (2019)
- Mu J, "Predicting lymph node metastasis in early gastric cancer patients : development and validation of a model", Future Oncol, 15, pp.3609~3617 (2019)
- Pyo JH, "A Risk-prediction model based on lymph-node metastasis for incorporation into a treatment algorithm for signet ring cell-type intramucosal gastric cancer", Ann Surg, 264, pp.1038~1043 (2016)
- Zheng Z, "A nomogram for predicting the likelihood of lymph node metastasis in early gastric patients", BMC Cancer, 16, pp.92~ (2016)
- Bang CS, "Establishing machine learning models to predict curative resection in early gastric cancer with undifferentiated histology : development and usability study", J Med Internet Res, 23, pp.e25053~ (2021)
- Kuo KM, "Predicting hospital-acquired pneumonia among schizophrenic patients : a machine learning approach", BMC Med Inform Decis Mak, 19, pp.42~ (2019)
- Thio Q, "Can machine-learning techniques be used for 5-year survival prediction of patients with chondrosarcoma?", Clin Orthop Relat Res, 476, pp.2040~2048 (2018)
- Yang YJ, "Application of artificial intelligence in gastroenterology", World J Gastroenterol, 25, pp.1666~1683 (2019)
- Zhou CM, "Machine learning predicts lymph node metastasis of poorly differentiated-type intramucosal gastric cancer", Sci Rep, 11, pp.1300~ (2021)
- Yun HR, "Machine learning improves the prediction rate of non-curative resection of endoscopic submucosal dissection in patients with early gastric cancer", Cancers(Basel), 14, pp.3742~ (2022)
- Watson DS, "Clinical applications of machine learning algorithms : beyond the black box", BMJ, 364, pp.l886~ (2019)
- Dietterich TG, "An experimental comparison of three methods for constructing ensembles of decision trees : bagging, boosting, and randomization", Mach Learn, 40, pp.139~157 (2000)
- Pedregosa F, "Scikit-learn : machine learning in Python", J Mach Learn Res, 12, pp.2825~2830 (2011)
- Chen T, "XGBoost", Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining (2016), Association for Computing Machinery
- Chu YN, "Feasibility of endoscopic treatment and predictors of lymph node metastasis in early gastric cancer", World J Gastroenterol, 25, pp.5344~5355 (2019)
- Folli S, "Risk factors for lymph node metastases and their prognostic significance in early gastric cancer(EGC)for the Italian Research Group for Gastric Cancer(IRGGC)", Jpn J Clin Oncol, 31, pp.495~499 (2001)
- Lee JH, "Risk factors for lymph node metastasis in patients with early gastric cancer and signet ring cell histology", Br J Surg, 97, pp.732~736 (2010)
- Zhu H, "Preoperative prediction for lymph node metastasis in early gastric cancer by interpretable machine learning models : a multicenter study", Surgery, 171, pp.1543~1551 (2022)
- Bibault JE, "Development and validation of a model to predict survival in colorectal cancer using a gradient-boosted machine", Gut, 70, pp.884~889 (2021)
- Kudo SE, "Artificial intelligence system to determine risk of T1 colorectal cancer metastasis to lymph node", Gastroenterology, 160, pp.1075~1084 (2021)
- Arima N, "Predictive factors for metachronous recurrence of early gastric cancer after endoscopic treatment", J Clin Gastroenterol, 29, pp.44~47 (1999)
- Na JE, "Machine learning model to stratify the risk of lymph node metastasis for early gastric cancer : a single-center cohort study", Cancers(Basel), 14, pp.1121~ (2022)
- Zhang Z, "Predictive analytics with gradient boosting in clinical medicine", Ann Transl Med, 7, pp.152~ (2019)